Dementia patients battle to receive proper information

People who suffer from dementia and those that care for them, say they are fighting a constant battle to receive proper information about their condition and its treatment according to new research launched today at the British Pharmaceutical Conference in Manchester.

The situation is so bad that many claim their concerns are often dismissed by health professionals as 'just old age'.

A new study carried out by pharmacists at the University of Bath aimed to explore the attitudes and concerns of people who suffer from dementia and those who care for them, about the medicines prescribed for it. One of the key objectives was to explore whether participants thought they were given sufficient information about medicines prescribed for dementia and its possible benefits or side effects.

The researchers started from the basis that, when diagnosed with any condition, people with the illness and those who care for them generally request further information on the disease, its prognosis and treatment options. If people receive suitable information, that includes an accurate account of the benefits of medicines versus their risks, they can then make an informed decision about whether or not to take a recommended medicine.

The researchers held a series of focus groups and semi-structured interviews as part of a qualitative study based at five local branches of the Alzheimer's Society in the South West of England. The results highlighted some key areas of concern, including:

  • People with dementia believe that their symptoms, and concerns about their condition, are often dismissed as 'just old age'.
  • People with dementia, and their carers feel that it is often a 'battle' to receive appropriate information.
  • They also believe that they are often provided with the wrong information and
  • They often feel guilty about continually having to ask for information.

Pharmacist Denise Taylor, who led the research, says that the results are a real cause for concern. "We found that people who take medicines for dementia, and those who care for them, describe an environment where access to information about medicines and carer support seems to be less than supportive," she says.

Denise Taylor goes on to say that perceived misinformation, or a complete lack of information from healthcare professionals, forces people to access other organisations for information, such as support groups or the internet. "This vulnerable population group are often unaware of where and who they can seek help from, but," she explains, "help is at hand."

"This study is part of a larger study that aims to develop a medicines management tool for the prescribing and monitoring of medicines for dementia by pharmacists and healthcare professionals. This would include advice about the type of information that patients with dementia and their carers would find helpful."

According to Denise Taylor it is hoped that the new tool will encourage pharmacists to be more proactively involved in the care of people with dementia and those that care for them. "Pharmacists have a key role to play in providing suitable information to people with dementia and their carers," she says.

http://www.rpsgb.org.uk/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New blood test could help identify patients at risk for cognitive impairment